You are here

Drug Safety Issues

Treatment targets advanced or metastatic HR-positive, HER2-negative cases
Patients with impaired liver function receiving too many doses
Products manufactured by PharmaTech were sold by three firms
Letter to health care providers warns of obesity treatment’s potential risks
Researchers suggest FDA regulation of yohimbe and energy products
Seeking to limit spread of infections, FDA clears improved device and manual
Praxbind reversed anticoagulant’s effect immediately in emergency settings
FDA requested the withdrawal because of a spike in abuse
Those most likely to abuse opioids are most likely to receive them
FDA’s post-marketing surveillance system is broken, expert says
Bacteria in water systems can cause deadly pneumonia
Finger of suspicion points to Ocrevus, but Tysabri may be the real culprit